Followers | 826 |
Posts | 119569 |
Boards Moderated | 14 |
Alias Born | 09/05/2002 |
Friday, March 09, 2018 1:20:08 PM
I'm surprised the stock is up so much today. FDA acceptance of the proposed assay is not the same as FDA acceptance of the assayed immunogenicity data, which is the issue of consequence for this program.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent CHRS News
- Coherus to Report First Quarter 2024 Financial Results on May 9, 2024 • GlobeNewswire Inc. • 05/01/2024 08:30:00 PM
- Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting • GlobeNewswire Inc. • 04/24/2024 02:02:18 PM
- Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting • GlobeNewswire Inc. • 04/08/2024 12:30:00 PM
- Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update • GlobeNewswire Inc. • 03/13/2024 08:01:00 PM
- Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 • GlobeNewswire Inc. • 03/05/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 11:22:53 AM
- Coherus Completes Divestiture of Ophthalmology Franchise • GlobeNewswire Inc. • 03/04/2024 06:00:00 AM
- Coherus BioSciences Announces New Employment Inducement Grants • GlobeNewswire Inc. • 02/23/2024 10:33:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:02:44 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 10:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:59:29 PM
- Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv • GlobeNewswire Inc. • 02/21/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 01:09:45 PM
- Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP • GlobeNewswire Inc. • 02/05/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 01:05:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 01:04:19 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:01:00 PM
- Sandoz to Acquire Cimerli Business from Coherus for $170 Million • Dow Jones News • 01/22/2024 06:59:00 AM
- Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in $170 Million Upfront All Cash Deal • GlobeNewswire Inc. • 01/22/2024 06:15:00 AM
- Coherus Presents Positive Phase 2 Clinical Data on Casdozokitug, a First-in-Class IL-27-Targeted Antibody, at the 2024 ASCO GI Cancers Symposium • GlobeNewswire Inc. • 01/18/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:41:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:39:46 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 12:37:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 11:58:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:14:31 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM